Methylenetetrahydrofolate reductase mutation (677C → T) negatively influences plasma homocysteine response to marginal folate intake in elderly women

Metabolism: Clinical and Experimental

Volumn 49, Issue 11, 2000, Pages 1440-1443

  Kauwell, G P A ^a   Wilsky, C E ^a   Cerda, J J ^a   Herrlinger Garcia, K ^a   Hutson, A D ^a   Theriaque, D W ^a   Boddie, A ^a   Rampersaud, G C ^a   Bailey, L B ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GENE MUTATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; NORMAL HUMAN; PRIORITY JOURNAL; RISK; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

EID: 0033756584     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2000.16555     Document Type: Article

References (30)

1. Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: Metabolic significance, risks and impact on folate requirement
2. Homocysteine and atherothrombosis
3. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: The result of a meta-analysis
4. The incidence of the gene for thermolabile methylenetetrahydrofolate reductase in African Americans
5. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes
6. Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (≥40 μmol/L)
7. The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia
8. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease
9. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease
10. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease
11. Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease
12. Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease
13. Homocysteine metabolism and risk of myocardial infarction: Relation with vitamins B-6, B-12, and folate
14. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer
15. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene
16. Methylenetetrahydrofolate reductase gene and coronary artery disease
17. Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation
18. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates. Implications for folate intake recommendations
19. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
20. The implications of genetic diversity for nutrient requirements: The case of folate
21. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
22. Folate status of elderly women following moderate folate depletion responds only to a higher folate intake
23. Folate status response to controlled folate intake in pregnant women
24. Application of tri-enzyme extraction for total folate determination in foods
25. Microbiological assay of folate
26. Lactobacillus casei microbiological assay of folic acid derivatives in 96-well microtiter plates
27. High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum
28. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
29. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages